– USA, MO – Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment of Dr. Myriam Curet, M.D., to its Board of Directors.
“We are delighted to have Myriam join the Stereotaxis Board of Directors,” said Chairman and CEO, David Fischel. “We look forward to benefiting from her highly relevant experience and significant expertise as we advance robotics across endovascular interventions.”
About Dr. Myriam Curet
Dr. Myriam Curet currently serves as EVP and CMO for Intuitive Surgical, the global leader and pioneer of robotic surgery. Dr. Curet joined Intuitive Surgical in 2005 and has since led the development of clinical evidence, physician education, and reimbursement and regulatory activities that have been instrumental to Intuitive Surgical’s growth across multiple clinical specialties. For more than 20 years, Dr. Curet has also served as a Clinical Professor of Surgery at Stanford University School of Medicine, with a part-time clinical appointment at the Palo Alto Veteran’s Administration Medical Center.
“Stereotaxis reminds me in many ways of Intuitive Surgical in our early years,” said Dr. Curet. “I’m impressed by Stereotaxis’ technology, clinical value, and strategy to positively transform endovascular medicine with robotics. I look forward to providing strategic guidance and contributing to the effort to build a highly successful and impactful company.”
Dr. Curet received her M.D. from Harvard Medical School and completed her general surgery residency at the University of Chicago.
About Stereotaxis
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere.
For more information: https://www.stereotaxis.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.